Premier Fund Managers Ltd Expands Position at Zoetis Inc. (NYSE:ZTS)

Financial Advisors


Premier Fund Managers Ltd increased its holding in Zoetis Inc. (NYSE:ZTS – Get Rating) by 746.4% in the fourth quarter, according to the latest 13F filings with the US Securities and Exchange Commission. The fund owned his 13,686 shares of the company’s stock after purchasing an additional 12,069 of his shares during the period. Premier Fund Managers Limited’s Zoetis holdings were valued at $7,633,000 at the end of the most recent reporting period.

Many other hedge funds and other institutional investors have also recently changed their holdings in the business. Prime Capital Investment Advisors LLC increased his Zoetis stake by 12.7% in the fourth quarter. Prime Capital Investment Advisors LLC now owns 2,133 of his shares worth $313,000 after purchasing an additional 241 of his shares last quarter. Glenview Trust Co increased its Zoetis stake by 14.3% in the fourth quarter. Glenview Trust Co now owns 3,682 shares of the company worth $540,000 after purchasing an additional 462 shares during the previous quarter. Cambridge Investment Research Advisors Inc. increased its shares in Zoetis by 14.9% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 69,783 shares worth $10,227,000 after purchasing an additional 9,040 shares during the previous quarter. IAG Wealth Partners LLC purchased a new position in Zoetis for approximately $29,000 in the fourth quarter. Finally, Van ECK Associates Corp increased its Zoetis stake by 2.8% in the fourth quarter. Van ECK Associates Corp now owns 986,666 shares worth $144,595,000 after purchasing an additional 26,857 shares in the previous quarter. Hedge funds and other institutional investors own 90.23% of the company’s shares.

Analyst sets new price target

ZTS has been the topic of several research analyst reports. StockNews.com began reporting on Zoetis in a research note on Thursday, March 16th. They gave the stock a “buy” rating.Bank Of America (Bofa) raised Zoetis’ price target to $200.00 from his $180.00, giving the company a “buy” rating in a research note on Tuesday, April 11. ” rating. Finally, Barclays raised his Zoetis price target from $250.00 to $260.00, giving the company an “Overweight” rating in its research notes on Tuesday, February 21. According to MarketBeat.com data, Zoetis currently has an average Buy rating and an average target price of $220.43.

Zoetis Insider Trading

In separate news, EVP Roxanne Lagano sold 4,338 shares of the company in a transaction on Tuesday, April 18th. The shares sold for an average of $175.94, giving her a total of $763,227.72. After the transaction, Executive Her Vice Her President now owns 26,357 shares of the company stock valued at $4,637,250.58. The transaction is disclosed in legal filings with the SEC and is available on her website at the SEC. The insider owns her 0.12% of the company’s shares.

Zoetis Volume 4.3 %

ZTS shares opened at $186.23 on Friday. The company has a 50-day simple moving average of $169.74 and a 200-day simple moving average of $159.55. The company has a debt to equity ratio of 1.49, a current ratio of 2.37 and a quick ratio of 1.63. Zoetis Inc. has a one-year low of $124.15 and a one-year high of $187.82. The stock has a market cap of $86.3 billion, a price/earnings ratio of 42.04, a PEG ratio of 2.76, and a beta of 0.77.

Zoetis (NYSE:ZTS – Get Rating) reported final results on Thursday, May 4. The company reported his earnings per share (EPS) of $1.31 for the quarter, $0.04 above analyst consensus expectations of $1.27 for him. Zoetis posted a net profit margin of 25.59% and a return on equity of 50.11%. The business generated $2 billion in revenue for the quarter, compared to analyst estimates of $2.02 billion. In the same quarter last year, the company recorded his EPS of $1.32. Business revenue for the quarter increased by 0.7% compared to the same period last year. Analysts expect Zoetis Inc., as a group, to post earnings per share of 5.39 this year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend payable on Thursday, June 1st. Dividends of $0.375 will be issued to shareholders of record on Friday, April 21. The ex-dividend date for this dividend is Thursday, April 20. This represents his $1.50 dividend and his 0.81% dividend yield on an annualized basis. Zoetis currently has a payout percentage of 33.86%.

Zoetis company profile

(get rating)

Zoetis, Inc discovers, develops, manufactures and commercializes pharmaceuticals, vaccines, diagnostic products and services, biodevices, genetic testing and precision animal health technologies. The company operates through US and international geographic segments.The US segment is involved in the US

Related item

Want to know which other hedge funds hold ZTS? Visit HoldingsChannel.com to get the latest Zoetis Inc. (NYSE:ZTS – Get Rating) 13F filings and insider trading.

Zoetis (NYSE:ZTS) Quarterly Institutional Ownership

This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.

Please hear this before considering Zoetis.

MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat identified five stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Zoetis wasn’t on the list.

Zoetis is currently rated as a ‘buy’ among analysts, but the top rated analysts believe these five stocks are better buys.

See 5 stocks here

(Almost) Everything You Need to Know About Covering the EV Market



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *